Neuroscience
Parkinson's Disease
100%
Alzheimer's Disease
57%
Neuromelanin
30%
Substantia nigra
25%
Synuclein
22%
Neurodegeneration
20%
Psychiatry
19%
Oxidative Stress
18%
Metabolic Pathway
15%
Neurodegenerative Disorder
15%
Lewy Body
15%
Proteomics
13%
Galactose
13%
Putamen
12%
Streptozotocin
10%
Tyrosine Hydroxylase
10%
Thalamus
10%
Selegiline
9%
In Vitro
8%
Xanthine Oxidase
8%
Psychopharmacology
8%
Dopaminergic
8%
Antidepressant
7%
Dopaminergic Neuron
7%
Microglia
7%
L-DOPA
6%
Cell Death
6%
Pathology of Parkinson's Disease
6%
Blood Plasma
6%
Blood Brain Barrier
6%
Amyloid Protein
6%
Treatment of Parkinson's Disease
6%
Alpha-Synuclein
6%
Diabetes Mellitus
6%
Neuroprotective Agent
6%
Dementia with Lewy Bodies
6%
Aldehyde Dehydrogenase Isoenzyme 2
5%
Glucagon-Like Peptide-1
5%
Occipital Lobe
5%
Insulin Receptor
5%
Astrocyte
5%
Multiple System Atrophy
5%
Chelating Agent
5%
Rasagiline
5%
Gene Expression
5%
Monoamine Oxidase B
5%
Aldehyde Dehydrogenase
5%
Melanin
5%
Substantia Nigra Pars Compacta
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
42%
Disease
33%
Alzheimer's Disease
17%
Therapeutic Drug Monitoring
13%
Amantadine
9%
Dopamine Receptor Stimulating Agent
8%
Galactose
8%
Coronavirinae
8%
Streptozotocin
8%
Psychopharmacology
8%
Antidepressant
8%
Pharmacotherapy
8%
Synuclein
7%
Levodopa
6%
Parkinsonism
6%
Neuroprotective Agent
6%
Attention Deficit Disorder
6%
Nerve Degeneration
6%
Amine Oxidase (Flavin Containing)
5%
SARS Coronavirus
5%
Rasagiline
5%
Selegiline
5%
Multiple Sclerosis
5%
Clinical Study
5%
Medicine and Dentistry
Parkinson's Disease
31%
Disease
18%
Alzheimer's Disease
12%
Neuromelanin
10%
Neurodegeneration
10%
Melanin
9%
Synuclein
7%
Melanoma
5%
Psychiatry
5%
Postencephalitic Parkinsonism
5%
